Shares of companies with Friedrich's Ataxia candidates are trading higher after Biogen announced the acquisition of Reata.
Portfolio Pulse from Benzinga Newsdesk
Shares of companies with Friedrich's Ataxia candidates are seeing an increase in their stock prices following Biogen's announcement of acquiring Reata.
July 28, 2023 | 4:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DSGN's stock price may increase due to Biogen's acquisition of Reata, as it also has Friedrich's Ataxia candidates.
DSGN, having Friedrich's Ataxia candidates, is likely to see a positive impact on its stock price due to the increased interest in this sector following Biogen's acquisition of Reata.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
LRMR's stock price may increase due to Biogen's acquisition of Reata, as it also has Friedrich's Ataxia candidates.
LRMR, having Friedrich's Ataxia candidates, is likely to see a positive impact on its stock price due to the increased interest in this sector following Biogen's acquisition of Reata.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
PTCT's stock price may increase due to Biogen's acquisition of Reata, as it also has Friedrich's Ataxia candidates.
PTCT, having Friedrich's Ataxia candidates, is likely to see a positive impact on its stock price due to the increased interest in this sector following Biogen's acquisition of Reata.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75